STERIS plc STE recently announced the completion of the previously-announced acquisition of Cantel Medical -- a global provider of infection prevention products and services primarily to endoscopy and ...

STERIS plc STE has been gaining from strong segmental growth. The integration of Cantel Medical continued successfully, strengthening STERIS’ Endoscopy offerings. However, a challenging macroeconomic ...

Steris reported strong growth in their Healthcare Products and Life Sciences segments, driven by procedure volume increases and market share gains. The company has raised their full-year organic ...

Medical device company STERIS Corp. (NYSE:STE) will acquire fellow device company US Endoscopy Inc. for $270 million to expand its presence in the GI market, the company announced today. “This is the ...

Steris ( ($STE) ) has released its Q2 earnings. Here is a breakdown of the information Steris presented to its investors. STERIS plc is a global ...

St. Paul-based Genii will become part of Steris' US Endoscopy business. Torax Medical agrees to sell to Johnson & Johnson subsidiary Teleflex buying med-tech company Vascular Solutions for $1 billion ...

STERIS STE has entered into an asset purchase agreement to sell the company’s Renal Care business to certain subsidiaries of Evoqua Water Technologies Corp. AQUA. The transaction value has been ...

MENTOR, Ohio — FDA to endoscope manufacturers on Monday: If you have labeled your devices for use with the STERIS Corp. System 1 sterilizer, your devices are misbranded. In a Feb. 22 letter, the U.S.

1. Boston Scientific. Headquartered in Marlborough, Mass., Boston Scientific manufactures a bevy of gastroenterology-focused products, including those for polypectomy, hemostasis and balloon dilation ...

STERIS plc STE has been gaining from continued strength across its operating segments. The company achieved substantial cost synergies in the first quarter of fiscal 2023 quarter, instilling optimism.